The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
1 other identifier
observational
50
1 country
1
Brief Summary
The study aims to compare the endothelial cell count in patients with pseudoexfoliation syndrome to the the endothelial cell count in normal patients above the age of 50.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedStudy Start
First participant enrolled
January 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 24, 2022
CompletedDecember 14, 2021
December 1, 2021
6 months
November 25, 2021
December 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to determine the possible association between pseudoexfoliation syndrome and corneal endothelial cell changes by measuring:
1. Endothelial cell density by specular microscopy to be categorized qualitatively into one of two groups (normal/abnormal cell count): A. A group with normal cell count (2100-3200 cells/mm2) B. A group with low or abnormal cell count (less than the previous range). 2. Pseudoexfoliation presence: to qualitatively categorize patients into one of two groups (pseudoexfoliation/ No pseudoexfoliation)
one year
Secondary Outcomes (1)
Endothelial cell morphology: to qualitatively categorize the patient subjectively into normal and abnormal shape using specular microscopy.
one year
Study Arms (2)
study group
patients with pseudoexfoliation fulfilling the inclusion criteria
control group
patients without pseudoexfoliation fulfilling the inclusion criteria
Interventions
no interventions as it is a case control observational study
Eligibility Criteria
patients above the age of 50 at the outpatient clinic
You may qualify if:
- \- Pesudoexfoliation Egyptian patients and controls groups must be at least 50 years old and matched from age.
- Controls will be selected from the same outpatient clinic.
You may not qualify if:
- Patients with history of previous intraocular surgeries, wearing contact lens and endothelial dystrophies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assuit university
Asyut, 71511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 25, 2021
First Posted
December 14, 2021
Study Start
January 24, 2022
Primary Completion
July 24, 2022
Study Completion
September 24, 2022
Last Updated
December 14, 2021
Record last verified: 2021-12